MERCIER JOHANNA (Chief Commercial Officer) sold 2.4% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $371.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/16/2026ACC: 0001782135-26-000024
Officer· Chief Commercial Officer
Since Jul 2019
-3K
Net shares
Net seller
$371.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.48K
Price / share
$123.42
Trade value
$182.66K
% of position
1.2%
6/15/2026
127.23K→125.75K
Common Stock
Direct
Shares
−1.07K
Price / share
$124.00
Trade value
$132.68K
% of position
0.9%
6/15/2026
125.75K→124.68K
Common Stock
Direct
Shares
−450.00
Price / share
$125.40
Trade value
$56.43K
% of position
0.4%
6/15/2026
124.68K→124.23K
Total
Net shares
−3K
Net value
-$371.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −1.48K | $123.42 | $182.66K | 1.2% | 127.23K | 125.75K |
| Common Stock Direct | 6/15/2026 | S · Sale | −1.07K | $124.00 | $132.68K | 0.9% | 125.75K | 124.68K |
| Common Stock Direct | 6/15/2026 | S · Sale | −450.00 | $125.40 | $56.43K | 0.4% | 124.68K | 124.23K |
| Total | −3K | -$371.76K | ||||||
Derivative Transactions0
No derivative transactions reported